Skip to main content
search

Interactive Global Value Dossier Platform for Market Access

interactive global value dossier platform

Turning evidence into market access impact with iGVD software

The goal hasn’t changed: a Global Value Dossier (GVD) is still fundamentally about informing decisions with evidence. But the increasingly complex stakeholder landscape means traditional approaches often fall short.  

The BaseCase global value dossier example app shows how to communicate complex evidence through a structured, interactive experience. It helps you reduce meeting prep time, handle objections more effectively, and prove value faster. Internally, it keeps teams aligned with access to the latest approved content – saving time by reducing internal questions and unnecessary back-and-forth.

Works with these devices

Mobile
Desktop
Tablet

What you’ll see and do in this global value dossier example app

This demo app isn’t about ‘Interferix’ as a treatment – it’s an example global value dossier app for pharma and market access teams, designed to integrate seamlessly into field workflows like pre-call planning, payer discussions, and objection handling.

Select different stakeholder perspectives and see how to tailor the value story to different audiences:

  • Payer perspective
  • Prescriber perspective
How to create a visually engaging, structured summary of clinical, economic, and epidemiological evidence
The ability to present complex data with interactive visuals, charts, and infographics (instead of static slides)
How to incorporate cost-effectiveness analyses and see how inputs impact outcomes in real-time
How to capture observations directly in the app for follow-up

  • Stakeholder feedback
  • Objections  
Provide instant access to structured PDF exports for offline use, ensuring consistency with the interactive experience and easing stakeholder adoption

Try the BaseCase iGVD software demo app

Explore a global value dossier pharma app for market access impact. Request access and try it now.

Why use a BaseCase interactive global value dossier app for market access?

The Interferix demo app is an example global value dossier app. With BaseCase iGVD software, you have the tools to increase stakeholder engagement and clearly demonstrate the value and impact of your therapy or medical device.

Turn complex evidence into clear value stories

Transform hundreds of pages into concise, visual narratives that are easy to understand and communicate.

Drive outcomes with tailored evidence

Easily adapt evidence to deliver the right value message across different audiences and geographies.

Maximize impact in every discussion

Understand how stakeholders engage with your content to identify what resonates, optimize messaging, and maximize impact.

Control global content, adapt locally

Keep global core evidence consistent with version control, while allowing affiliates to adapt content for local HTA requirements.

Capture and act on feedback

Collect objections and feedback directly in the app to improve your value story over time.

Keep stakeholders’ attention where it matters

Having a centralized value story removes the distraction of switching between PowerPoint, Excel and PDFs during critical discussions.

Try the BaseCase iGVD software demo app

Have a go yourself with the BaseCase interactive global value dossier platform. Request access and start exploring today.

Frequently asked questions

What is an interactive global value dossier platform?

An interactive global value dossier platform transforms traditional, static GVDs into dynamic, digital experiences. It enables teams to present clinical and economic evidence in a more engaging, tailored way, helping stakeholders better understand value and make informed decisions.

What is iGVD software and how does it support market access?

iGVD software provides a platform where you can create, manage, and deliver digital global value dossiers. It supports pharma and market access teams by making complex evidence easier to communicate. Content can be tailored for different stakeholders, enabling more engaging, data-driven discussions.

Can I see an example global value dossier in this demo app?

Yes. This Interferix demo app is a real-world global value dossier example app. You will see first-hand how clinical, economic, and epidemiological evidence can be presented in an interactive format. It illustrates how a traditional dossier can be transformed into a more engaging and accessible digital experience.

What is a global value dossier in pharma?

A global value dossier in pharma is a comprehensive document containing clinical and economic evidence related to a new pharmaceutical therapy or product. The dossier typically includes data such as product overviews, disease burden, clinical study results, economic models, and real-world evidence. The aim of a GVD is to support market access across regions by delivering consistent, up-to-date evidence. It aligns global and local teams and enables tailored value narratives for different payer needs.

How is a global value dossier used in pharma?

A global value dossier is used in pharma to communicate the clinical and economic value of a therapy to payers, healthcare providers, and other stakeholders. Traditional dossiers comprise fragmented, static documents, such as spreadsheets, PDFs and PowerPoint files. A digital GVD provides a single platform that unifies clinical evidence, economic models, and payer-specific context. Because digital GVDs are interactive and analysis can be performed live, payers and decision makers become active participants in the process. This leads to deeper, more meaningful engagement, and a greater chance of directly impacting commercial outcomes.

What is the difference between an AMCP dossier and an investigational medicinal product dossier (IMPD)?

An AMCP dossier is a standardized document used in the United States to provide payers with clinical and economic evidence to support formulary and reimbursement decisions. AMCP dossiers focus on value communication for market access. On the other hand, an investigational medicinal product dossier (IMPD) is a regulatory document used in clinical trials to provide detailed information on the quality, safety, and manufacture of a new drug or product. IMPDs are designed for regulatory submission and clinical development.